Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-15

FDA Approved: SOLOSEC — Original Application (Evofem Inc.)

View source ↗

Summary

FDA approved SOLOSEC (secnidazole) under Evofem Inc.'s original NDA for the treatment of bacterial vaginosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOLOSEC (secnidazole)

Snippet

ORIG AP for SOLOSEC (SECNIDAZOLE)